title: Efficacy of ilaprazole in the treatment of duodenal ulcers: a meta-analysis.
abstract: OBJECTIVE
  To compare the efficacy and tolerance of ilaprazole compared with other proton pump inhibitors (PPIs) in the treatment of duodenal ulcer.
  
  
  METHODS
  An electronic database search of Medline, Embase, the Cochrane controlled trials register, Web of Science, PubMed, and the Chinese Biomedical Literature Database (updated to July 2013), and manual searches were conducted. A meta-analysis of randomized controlled trials comparing the efficacy and tolerance of ilaprazole and other PPIs in the treatment of duodenal ulcers was performed.
  
  
  RESULTS
  Five articles involving 1481 patients were included. The meta-analysis showed no difference in the 4-wk healing rate between ilaprazole and other PPIs [89.7% vs 87.0%; relative risk (RR) = 1.02; 95%CI: 0.98-1.06; Z = 1.00; P = 0.32]. The results did not change in the sensitivity analyses. The meta-analysis indicated that the adverse effect rate in the ilaprazole group was lower than that in the control group, but the difference was not significant (9.7% vs 13.0%; RR = 0.81; 95%CI: 0.60-1.07; Z = 1.47; P = 0.14).
  
  
  CONCLUSIONS
  Ilaprazole is a highly effective and safe PPI in the treatment of duodenal ulcers. Ilaprazole can be recommended as a therapy for acid-related disorders, especially in Asian populations.
authors.affiliation: Xi-Qing Ji, Jun-Feng Du, Gang Chen, Guang Chen, Bo Yu, Department of General Surgery, General Hospital of Beijing Military Command of People's Liberation Army, Beijing 100700, China.
authors.forename: Xi-Qing
authors.initials: XQ
authors.lastname: Ji
authors.affiliation: Xi-Qing Ji, Jun-Feng Du, Gang Chen, Guang Chen, Bo Yu, Department of General Surgery, General Hospital of Beijing Military Command of People's Liberation Army, Beijing 100700, China.
authors.forename: Jun-Feng
authors.initials: JF
authors.lastname: Du
authors.affiliation: Xi-Qing Ji, Jun-Feng Du, Gang Chen, Guang Chen, Bo Yu, Department of General Surgery, General Hospital of Beijing Military Command of People's Liberation Army, Beijing 100700, China.
authors.forename: Gang
authors.initials: G
authors.lastname: Chen
authors.affiliation: Xi-Qing Ji, Jun-Feng Du, Gang Chen, Guang Chen, Bo Yu, Department of General Surgery, General Hospital of Beijing Military Command of People's Liberation Army, Beijing 100700, China.
authors.forename: Guang
authors.initials: G
authors.lastname: Chen
authors.affiliation: Xi-Qing Ji, Jun-Feng Du, Gang Chen, Guang Chen, Bo Yu, Department of General Surgery, General Hospital of Beijing Military Command of People's Liberation Army, Beijing 100700, China.
authors.forename: Bo
authors.initials: B
authors.lastname: Yu
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D044466:Asian People; D016009:Chi-Square Distribution; D004381:Duodenal Ulcer / Q000175:diagnosis / Q000188:drug therapy* / Q000208:ethnology; D006801:Humans; D016017:Odds Ratio; D054328:Proton Pump Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D054328:Proton Pump Inhibitors; C119615:ilaprazole
keywords: Duodenal ulcer; Ilaprazole; Meta-analysis; Proton pump inhibitor